FPT Achieves Select Tier Partnership with Databricks, Strengthening Its Regional and Global Data & AI Capabilities
"By combining FPT's global delivery strength and Databricks' cutting-edge technology, we are well-positioned to accelerate data-driven transformation for our clients worldwide."
The Select Tier is the second-highest level in the Databricks partner ecosystem. It recognizes partners who demonstrate a strong track record of expertise, delivery capability and alignment with Databricks technologies. FPT achieved this status through significant investment in talent development, with nearly 100 technical certifications and over 40 certifications in pre-sales and leadership roles across its team.
This recognition builds on the companies' recent partnership to drive AI-powered digital transformation in Japan. Across the APJ region, FPT has successfully delivered Databricks solutions for major global enterprises in industries such as insurance, manufacturing and energy. These projects have solved complex data challenges, built modern data platforms and accelerated AI adoption across the business.
As a Select Tier Partner, FPT has access to a range of exclusive benefits from Databricks, including expert training, enhanced technical support and closer sales collaboration. These advantages enable FPT to offer even greater value to enterprise clients, especially in key sectors such as banking, manufacturing, and retail, who are pursuing large-scale data transformation.
'Congratulations to FPT on achieving Databricks Select Tier Partner status. This milestone reflects their growing leadership in delivering enterprise-grade data and AI solutions across the region,' said Greg Taylor, Vice President of Partners, APJ, Databricks. 'By combining FPT's local expertise with the power of the Databricks Data Intelligence Platform, we're helping more customers across APJ modernise their data foundations, operationalise AI at scale, and turn data into timely, actionable insights that drive meaningful business outcomes.'
Commenting on the announcement, Frank Bignone, FPT Software Vice President and Director of Digital Transformation Division, FPT Corporation, added: 'We are proud to reach this Select Tier Partnership with Databricks, a global leader in unified data and AI. This milestone reflects our deep commitment to building world-class capabilities in modern data platforms, scalable AI solutions, and enterprise-grade analytics. By combining FPT's global delivery strength and Databricks' cutting-edge technology, we are well-positioned to accelerate data-driven transformation for our clients worldwide.'
Looking ahead, FPT continues to deepen its talent capabilities, with a focus on growing the number of professionals certified at the advanced Databricks Data Engineer Professional level. FPT and Databricks are also planning joint events and go-to-market activities in key markets such as the United States and Japan. These initiatives aim to generate new business opportunities and strengthen FPT's position as a trusted data and AI partner on a global scale.
About FPT
FPT Corporation (FPT) is a globally leading technology and IT services provider headquartered in Vietnam and operates in three core sectors: Technology, Telecommunications, and Education. Over more than three decades, FPT has consistently delivered impactful solutions to millions of individuals and tens of thousands of organizations worldwide. Committed to elevating Vietnam's position on the global tech map and delivering world-class AI-enabled solutions for global enterprises, the Corporation focuses on three critical transformations: Digital Transformation, Intelligence Transformation, and Green Transformation. In 2024, FPT reported a total revenue of USD 2.47 billion and a workforce of over 54,000 employees across its core businesses. For more information about FPT's global IT services, please visit https://fptsoftware.com/.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Verge
a day ago
- The Verge
OpenAI releases a free GPT model that can run on your laptop
OpenAI is releasing a new open-weight model dubbed GPT-OSS that can be downloaded for free, be customized, and even run on a laptop. The model comes in two variants: 120-billion-parameter and 20-billion-parameter versions. The bigger version can run on a single Nvidia GPU and performs similarly to OpenAI's existing o4-mini model, while the smaller version performs similarly to o3-mini and runs on just 16GB of memory. Both model versions are being released today via platforms like Hugging Face, Databricks, Azure, and AWS under the Apache 2.0 license, which allows them to be widely modified for commercial purposes. This is OpenAI's first open-weight model in over six years, years before the debut of ChatGPT. Until earlier this year, CEO Sam Altman cited safety concerns as the main reason for not releasing a follow-up. Meanwhile, developers have flocked to open models due to their lower cost and customizability. In January, after the rise of DeepSeek, Altman said that OpenAI had 'been on the wrong side of history' by not releasing its own open models. Now, OpenAI is reasserting itself with an open-weight model that it says can perform reasoning tasks, browse the web, write code, and operate agents via the company's existing APIs. 'I think a lot of people are actually surprised to know that the vast majority of our customers are already using a lot of open models,' Chris Cook, an OpenAI researcher, said during a media briefing. 'We wanted to plug that gap and allow them to use our technology across the board.' On the safety front, OpenAI says that GPT-OSS is its most rigorously tested model to date, and that it was tested with external safety firms to ensure it doesn't pose risks in areas like cybersecurity and biological weapons. The model's chain of thought, or visible process used to arrive at an answer, is shown 'to monitor model misbehavior, deception and misuse,' according to a company press release. Its output is text-only and, like all of OpenAI's models, GPT-OSS's training data is undisclosed. 'The team really cooked with this one.' OpenAI hasn't shared benchmarks comparing GPT-OSS to other open models like Llama, DeepSeek, or Google's Gemma. Both variants of GPT-OSS perform similarly to OpenAI's closed reasoning models on coding tasks and tests like Humanity's Last Exam. 'These are incredible models,' said OpenAI co-founder Greg Brockman. 'The team really cooked with this one.' OpenAI isn't committing to a release schedule for future versions of GPT-OSS, but it hopes that the model will be used by smaller developers and companies that want more control over how their data is used. 'We've always believed that if you lower the barrier to access, then innovation just goes up,' said Brockman. 'You let people hack, then they will do things that are incredibly surprising.' Posts from this author will be added to your daily email digest and your homepage feed. See All by Alex Heath Posts from this topic will be added to your daily email digest and your homepage feed. See All AI Posts from this topic will be added to your daily email digest and your homepage feed. See All OpenAI
Business Upturn
2 days ago
- Business Upturn
Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology
to explore external market opportunities as a potential revenue source. Beta version to incorporate oncology targets, enhancing the accuracy and diversity of the PredicTcell model and potentially accelerating cancer immunotherapy development. to develop enhanced analytics and visualization tools, for the PredicTcell model to support its internal R&D teams. WARREN, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) — Tevogen ('Tevogen Bio Holdings Inc.' or 'Company') (Nasdaq: TVGN) today announced that its artificial intelligence initiative, is expanding its collaboration with Microsoft (Nasdaq: MSFT) and Databricks, to build the beta version of its foundational PredicTcell model. Powered by the Databricks Data Intelligence Platform and backed by their innovative engineering teams, has begun curating a dataset focused on oncology. The dataset, aggregated with the initial virology dataset. aims to improve upon the accuracy of the alpha version of PredicTcell model. This next phase of development builds on recently published international patent application (WO 2025/129197), which outlines novel machine learning systems for predicting immunologically active peptides, a critical step in developing targeted therapies for cancers and infectious diseases. 'We have been extremely fortunate to work with such great organizations like Microsoft and Databricks to build the alpha version of our foundational AI model,' said Mittul Mehta, Chief Information Officer and Head of 'Oncology represents one of the most impactful areas for AI in drug discovery, given the complexity of the disease and the limited availability of high-quality datasets.' Forward Looking Statements This press release contains certain forward-looking statements, including without limitation statements relating to: Tevogen's plans for its research and manufacturing capabilities; expectations regarding future growth; expectations regarding the healthcare and biopharmaceutical industries; and Tevogen's development of, the potential benefits of, and patient access to its product candidates for the treatment of infectious diseases and cancer. Forward-looking statements can sometimes be identified by words such as 'may,' 'could,' 'would,' 'expect,' 'anticipate,' 'possible,' 'potential,' 'goal,' 'opportunity,' 'project,' 'believe,' 'future,' and similar words and expressions or their opposites. These statements are based on management's expectations, assumptions, estimates, projections and beliefs as of the date of this press release and are subject to a number of factors that involve known and unknown risks, delays, uncertainties and other factors not under the company's control that may cause actual results, performance or achievements of the company to be materially different from the results, performance or other expectations expressed or implied by these forward-looking statements. Factors that could cause actual results, performance, or achievements to differ from those expressed or implied by forward-looking statements include, but are not limited to: that Tevogen will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; changes in the markets in which Tevogen competes, including with respect to its competitive landscape, technology evolution, or regulatory changes; changes in domestic and global general economic conditions; the risk that Tevogen may not be able to execute its growth strategies or may experience difficulties in managing its growth and expanding operations; the risk that Tevogen may not be able to develop and maintain effective internal controls; the failure to achieve Tevogen's commercialization and development plans and identify and realize additional opportunities, which may be affected by, among other things, competition, the ability of Tevogen to grow and manage growth economically and hire and retain key employees; the risk that Tevogen may fail to keep pace with rapid technological developments to provide new and innovative products and services or make substantial investments in unsuccessful new products and services; risks related to the ability to develop, license or acquire new therapeutics; the risk of regulatory lawsuits or proceedings relating to Tevogen's business; uncertainties inherent in the execution, cost, and completion of preclinical studies and clinical trials; risks related to regulatory review, approval and commercial development; risks associated with intellectual property protection; Tevogen's limited operating history; and those factors discussed or incorporated by reference in Tevogen's Annual Report on Form 10-K. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Tevogen undertakes no obligation to update any forward-looking statements, except as required by applicable law. Contacts Tevogen Bio CommunicationsT: 1 877 TEVOGEN, Ext 701 [email protected]
Yahoo
5 days ago
- Yahoo
Figma's IPO was a huge hit. Here are the companies betting markets think are next in line to debut.
Figma had a wild market debut on Thursday that generated excitement for more IPOs. Figma's debut follows high-profile IPOs from Circle and CoreWeave earlier this year. With hopes that the IPO market is opening up, betting markets have their eye on the next firms to go public. Figma's wild trading debut on Thursday is generating a lot of excitement for more tech IPOs. After an underwhelming 2024 that saw little in the way of IPO activity, the market has bounced back, with several high profile debuts from, Figma, CoreWeave, and Circle Internet Group. Figma's first day of trading saw a collosal 250% pop, withmomentum carrying into a second day on Friday. But online bettors are already focused on spotting the next major IPO. Here's the list of the stocks most likely to formally announce an IPO this year, according to bettors on Kalshi: Klarna: 83% chance Discord: 45% chance Cerebras Systems: 39% chance Databricks: 30% chance Stripe: 19% chance Klarna has been eyeing an IPO for months. It initially filed to go public in March, but paused due to volatility stemming from President Donald Trump's tariffs. However, sources told Bloomberg this week that it could resume plans for an IPO as soon as September. Meanwhile, the popular social media platform Discord has been seen as a likely IPO candidate since Reddit's debut in March 2024. Reddit soared on Friday, spiking 20% on a strong earnings report, bucking a wider sell-off related to tariff jitters and the job market. Both Cerebras and Databricks have seen their odds bolstered by the debut of CoreWeave this year, an AI infrastructure company that is credited with kicking off the 2025 IPO boom. Despite early post-IPO volatility, the stock has outperformed, up 166% this year. Payments firm Stripe rounds out the list, with investors anticipating its debut for years. Read the original article on Business Insider Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
